Cargando…
Development of sequence-specific antimicrobials based on programmable CRISPR-Cas nucleases
Antibiotics target conserved bacterial cellular pathways or growth functions and therefore cannot selectively kill specific members of a complex microbial population. Here, we develop programmable, sequence-specific antimicrobials using the RNA-guided nuclease Cas9(1, 2) delivered by a bacteriophage...
Autores principales: | Bikard, David, Euler, Chad, Jiang, Wenyan, Nussenzweig, Philip M., Goldberg, Gregory W., Duportet, Xavier, Fischetti, Vincent A., Marraffini, Luciano A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317352/ https://www.ncbi.nlm.nih.gov/pubmed/25282355 http://dx.doi.org/10.1038/nbt.3043 |
Ejemplares similares
-
Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting
por: Goldberg, Gregory W., et al.
Publicado: (2014) -
Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system
por: Bikard, David, et al.
Publicado: (2013) -
Control of gene expression by CRISPR-Cas systems
por: Bikard, David, et al.
Publicado: (2013) -
Cas9 specifies functional viral targets during CRISPR-Cas adaptation
por: Heler, Robert, et al.
Publicado: (2015) -
CRISPR-assisted editing of bacterial genomes
por: Jiang, Wenyan, et al.
Publicado: (2013)